Oral misoprostol vs vaginal misoprostol
Oral misoprostol showed no clear difference in admission to neonatal intensive care unit compared with vaginal misoprostol (moderate certainty).
- RR 1.03 [0.86, 1.23]23 studies · 4450 participantsModerate
Oral misoprostol showed no clear difference in admission to neonatal intensive care unit compared with vaginal misoprostol (moderate certainty).
Oral misoprostol showed no clear difference in admission to neonatal intensive care unit compared with vaginal dinoprostone (low certainty).
It is very uncertain whether oral misoprostol changes admission to neonatal intensive care unit compared with intravenous oxytocin (very low certainty).
Oral misoprostol showed no clear difference in admission to neonatal intensive care unit compared with mechanical methods (low certainty).
Vaginal misoprostol showed no clear difference in neonatal intensive care unit admission compared with placebo (low certainty).
Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with low‐dose vaginal misoprostol (low certainty).
Balloon (Foley or ATAD) showed no clear difference in neonatal intensive care unit admission compared with low‐dose oral misoprostol (low certainty).